Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group

Racial differences in donor source, matching, rejection and outcome in Pediatric renal transplantation (PRT)

Go back to Resources

Racial differences in donor source, matching, rejection and outcome in Pediatric renal transplantation (PRT)

Authors:

Location:

Go back to Resources

Prospective Grading of Graft versus Host Disease (GVHD) After Unrelated Donor BMT: A Grading Algorithm versus Blinded Expert Panel Review

Go back to Resources

Prospective Grading of Graft versus Host Disease (GVHD) After Unrelated Donor BMT: A Grading Algorithm versus Blinded Expert Panel Review

Authors:

Location:

Go back to Resources

Pretransplant peritoneal dialysis and graft thrombosis following pediatric kidney transplantation: a NAPRTCS report

Go back to Resources

Pretransplant peritoneal dialysis and graft thrombosis following pediatric kidney transplantation: a NAPRTCS report

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

North American Pediatric Renal Transplant Cooperative Study. Outcome of renal transplantation in adolescents with focal segmental glomerulosclerosis

Go back to Resources

North American Pediatric Renal Transplant Cooperative Study. Outcome of renal transplantation in adolescents with focal segmental glomerulosclerosis

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Mycophenolate, tacrolimus and post-transplant lymphoproliferative disorder: a report of the North American Pediatric Renal Transplant Cooperative Study

Go back to Resources

Mycophenolate, tacrolimus and post-transplant lymphoproliferative disorder: a report of the North American Pediatric Renal Transplant Cooperative Study

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Hospitalization for CMV in pediatric renal transplant patients treated with MMF vs. Azathioprine: a North American Pediatric Renal Cooperative Study (NAPRTCS) Report

Go back to Resources

Hospitalization for CMV in pediatric renal transplant patients treated with MMF vs. Azathioprine: a North American Pediatric Renal Cooperative Study (NAPRTCS) Report

Authors:

Location:

Go back to Resources

Health-related quality of life in cancer prevention clinical trials

Go back to Resources

Health-related quality of life in cancer prevention clinical trials

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial

Go back to Resources

Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Ethnicity and birth outcomes

Go back to Resources

Ethnicity and birth outcomes

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Epidermal growth factor receptor inhibitors in clinical trials

Go back to Resources

Epidermal growth factor receptor inhibitors in clinical trials

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 137
  • Page 138
  • Page 139
  • Page 140
  • Current page 141
  • Page 142
  • Page 143
  • Page 144
  • Page 145
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification